Pfizer product analyses
A tighter look at the products that matter most to Pfizer, along with the free, open, decentralized, or cooperative alternatives already creating pricing pressure and the original disruption concepts that could widen that pressure further.
Products
Where the moat actually touches users
These pages zoom into the products and services that matter most to each company, the alternatives already nibbling at them, and 2 structured disruption concepts across the current product set.
Anticoagulant medicine
1 conceptEliquis is an oral anticoagulant used to reduce stroke and blood-clot risk in indicated patients.
Paper trail
Company-level source stack
These sources shaped the scoring and writing. The site is opinionated, but it should not behave like it is improvising facts in a dark room.
Pfizer · annual report
Primary company review for business overview, product portfolio context, and 2025 performance narrative.
Reviewed 2026-05-27
Pfizer · investor relations
Investor release with 2025 revenue context for Eliquis, Comirnaty, and other major Pfizer products.
Reviewed 2026-05-27
StockAnalysis · market data
Market-data reference for trailing valuation, revenue, net income, and P/E context near the review date.
Reviewed 2026-05-27